“BARRS Pharmaceuticals exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure.” – Business Day (3 Feb 2026)
Barrs and its sister company, Innovata Pharmaceuticals, entered business rescue in December 2025, alongside parent group Avacare.
The SA subsidiary of the Indian generics group will acquire 78% of Barrs for R92m.
Hetero SA will now step in to cover Barrs’ portion of the state’s latest HIV treatment tender at the price set out in the tender award.